- Home
- CLBT
CLBT
Cellebrite DI Ltd.
as 11-15-2024 4:00pm EST
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
| Founded: | 1999 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.0B | IPO Year: | N/A |
| Target Price: | $19.25 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.64 - $21.00 | Next Earning Date: | 11-06-2024 |
| Revenue: | $385,167,000 | Revenue Growth: | 25.82% |
| Revenue Growth (this year): | 25.3% | Revenue Growth (next year): | 17.22% |
Latest Cellebrite DI Ltd. News
CLBT Breaking Stock News: Dive into CLBT Ticker-Specific Updates for Smart Investing
Investor's Business Daily
3 days ago
AI Stock Cellebrite Fights For Support At Key Level After 65% Rally
Simply Wall St.
9 days ago
Cellebrite DI Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GlobeNewswire
11 days ago
CORRECTION: Cellebrite Announces Third-Quarter 2024 Results
GlobeNewswire
11 days ago
Yossi Carmil to Step Down as CEO After Nearly 20 Years
GlobeNewswire
11 days ago
Cellebrite Announces Third-Quarter 2024 Results
Simply Wall St.
12 days ago
High Growth Tech Stocks To Watch In November 2024
GuruFocus.com
12 days ago
Cellebrite DI Ltd (CLBT) Q3 2024: Everything You Need To Know Ahead Of Earnings
Simply Wall St.
13 days ago
At US$18.53, Is It Time To Put Cellebrite DI Ltd. (NASDAQ:CLBT) On Your Watch List?
Compare CLBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLBT Cellebrite DI Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.